Skip to main content

Table 3 Stratified analyses of lncRNA PRNCR1 polymorphisms with clinical features in patients with CRC (minor allele vs. major allele)

From: Association between polymorphisms in long non-coding RNA PRNCR1 in 8q24 and risk of colorectal cancer

Polymorphisms Adjusted OR for age and gender (95% CI)/p
Tumor size (≥5 cm) Differentiated status (poorly) Clinical stage (III-IV) Metastasis (yes)
rs1016343C/T 0.82(0.59-1.13)/0.22 1.05(0.72-1.55)/0.79 1.07(0.77-1.49)/0.70 1.27(0.91-1.78)/0.16
rs13252298A/G 1.07(0.75-1.52)/0.72 1.21(0.80-1.82)/0.37 0.85(0.59-1.21)/0.36 0.76(0.53-1.10)/0.15
rs7007694T/C 0.74(0.51-1.08)/0.11 0.46(0.28-0.77)/0.003 1.04(0.71-1.51)/0.85 1.11(0.76-1.62)/0.59
rs16901946A/G 0.84(0.59-1.22)/0.36 0.59(0.37-0.94)/0.03 1.09(0.76-1.58)/0.64 1.26(0.87-1.83)/0.22
rs1456315A/G 1.56(1.10-2.23)/0.01 1.54(1.03-2.31)/0.04 1.16(0.81-1.66)/0.43 1.06(0.73-1.52)/0.77
  1. CRC: colorectal cancer; OR: odds ratio; CI: confidence interval.
  2. The smaller size, well differentiated status, clinical stage I-II, and the ones without metastasis were made as references, respectively.